Evolving Pharmacovigilance Beyond a Cost Center
Safety is evolving rapidly. There is a major, emerging opportunity ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
Safety is evolving rapidly. There is a major, emerging opportunity ...
Nothing evolves within a vacuum. While today we can transmit ...
What will the next generation of reporting and analytics in ...
Concepts once thought to be theoretical are now a reality ...
The very basis of pharmacovigilance is to detect, collect, monitor, ...
The management of data within organizations has far-reaching effects, as ...
Most regulatory information management (RIM) systems were designed to capture ...
Managing a clinical trial is no small feat. Documents must ...
The Shift to the Cloud Historically, firms relied heavily on ...
The European Union (EU) Clinical Trials Regulation (CTR) harmonizes the ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved